The market for acute respiratory diagnosis and chronic respiratory management for Asthma and COPD for all age democratic (except only adult for COPD) are still very lucrative, there's no risk here.......
- Forums
- ASX - By Stock
- Ann: Proposed Acquisition of ResApp Health by Pfizer
The market for acute respiratory diagnosis and chronic...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 281 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)